These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9809712)

  • 1. Economic evaluation in schistosomiasis: valuation of health states preferences. A research note.
    Kirigia JM
    Health Econ; 1998 Sep; 7(6):551-6. PubMed ID: 9809712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual differences in the use of the response scale determine valuations of hypothetical health states: an empirical study.
    Essink-Bot ML; Stuifbergen MC; Meerding WJ; Looman CW; Bonsel GJ;
    BMC Health Serv Res; 2007 Apr; 7():62. PubMed ID: 17466068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality-of-life valuations of advanced breast cancer by New Zealand women.
    Milne RJ; Heaton-Brown KH; Hansen P; Thomas D; Harvey V; Cubitt A
    Pharmacoeconomics; 2006; 24(3):281-92. PubMed ID: 16519549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Health valuations for patients with chronic ischemic heart disease].
    Meder M; Farin E
    Rehabilitation (Stuttg); 2011 Aug; 50(4):222-31. PubMed ID: 21626474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Productivity costs in health-state valuations : does explicit instruction matter?
    Krol M; Brouwer W; Sendi P
    Pharmacoeconomics; 2006; 24(4):401-14. PubMed ID: 16605285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A social preference valuations set for EQ-5D health states in Flanders, Belgium.
    Cleemput I
    Eur J Health Econ; 2010 Apr; 11(2):205-13. PubMed ID: 19582490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Description and valuation of health-related quality of life among the general public in Japan by the EuroQol.
    Hisashige A; Mikasa H; Katayama T
    J Med Invest; 1998 Aug; 45(1-4):123-9. PubMed ID: 9864973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health State Values Derived from People with Multiple Sclerosis for a Condition-Specific Preference-Based Measure: Multiple Sclerosis Impact Scale-Eight Dimensions-Patient Version (MSIS-8D-P).
    Goodwin E; Green C; Hawton A
    Value Health; 2018 Nov; 21(11):1338-1345. PubMed ID: 30442282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient and public preferences for health states associated with AMD.
    Butt T; Dunbar HM; Morris S; Orr S; Rubin GS
    Optom Vis Sci; 2013 Aug; 90(8):855-60. PubMed ID: 23811607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valuations of EQ-5D health states: are the United States and United Kingdom different?
    Johnson JA; Luo N; Shaw JW; Kind P; Coons SJ
    Med Care; 2005 Mar; 43(3):221-8. PubMed ID: 15725978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstetrical outcome valuations by patients, professionals, and laypersons: differences within and between groups using three valuation methods.
    Bijlenga D; Birnie E; Mol BW; Bonsel GJ
    BMC Pregnancy Childbirth; 2011 Nov; 11():93. PubMed ID: 22078302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-valuation and societal valuations of health state differ with disease severity in chronic and disabling conditions.
    McPherson K; Myers J; Taylor WJ; McNaughton HK; Weatherall M
    Med Care; 2004 Nov; 42(11):1143-51. PubMed ID: 15586842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health state valuations from the general public using the visual analogue scale.
    Gudex C; Dolan P; Kind P; Williams A
    Qual Life Res; 1996 Dec; 5(6):521-31. PubMed ID: 8993098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health state valuation in low- and middle-income countries: a systematic review of the literature.
    Kularatna S; Whitty JA; Johnson NW; Scuffham PA
    Value Health; 2013; 16(6):1091-9. PubMed ID: 24041360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.
    Kreimeier S; Oppe M; Ramos-Goñi JM; Cole A; Devlin N; Herdman M; Mulhern B; Shah KK; Stolk E; Rivero-Arias O; Greiner W
    Value Health; 2018 Nov; 21(11):1291-1298. PubMed ID: 30442276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a case for using visual analogue scale valuations in cost-utility analysis?
    Parkin D; Devlin N
    Health Econ; 2006 Jul; 15(7):653-64. PubMed ID: 16498700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valuation of EQ-5D health states in Poland: first TTO-based social value set in Central and Eastern Europe.
    Golicki D; Jakubczyk M; Niewada M; Wrona W; Busschbach JJ
    Value Health; 2010; 13(2):289-97. PubMed ID: 19744296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EuroQol: health-related quality of life measurement. Valuations of health states by the general public in Norway.
    Nord E
    Health Policy; 1991 Jun; 18(1):25-36. PubMed ID: 10112299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.